07.01.2013 Views

Mayo Test Catalog, (Sorted By Test Name) - Mayo Medical ...

Mayo Test Catalog, (Sorted By Test Name) - Mayo Medical ...

Mayo Test Catalog, (Sorted By Test Name) - Mayo Medical ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

CA25<br />

9289<br />

CA153<br />

81607<br />

individuals of Eastern European Jewish descent. Obstet Gynecol 2009;Oct;114(4):950-953 3. Matalon R:<br />

Canavan disease: diagnosis and molecular analysis. Genet <strong>Test</strong>ing 1997;1:21-25<br />

Cancer Antigen 125 (CA 125), Serum<br />

Clinical Information: Cancer antigen 125 (CA 125) is a glycoprotein antigen normally expressed<br />

in tissues derived from coelomic epithelia (ovary, fallopian tube, peritoneum, pleura, pericardium,<br />

colon, kidney, stomach). Elevated serum CA 125 levels are seen in many patients with cancer of the<br />

ovary; the percentage of positive cases increases with cancer stage. Elevated serum CA 125 levels have<br />

been reported in individuals with a variety of nonovarian malignancies including cervical, liver,<br />

pancreatic, lung, colon, stomach, biliary tract, uterine, fallopian tube, breast, and endometrial<br />

carcinomas. Elevated serum CA 125 levels have been reported in individuals with a variety of<br />

nonmalignant conditions including: cirrhosis, hepatitis, endometriosis, first trimester pregnancy, ovarian<br />

cysts, and pelvic inflammatory disease. Elevated levels during the menstrual cycle also have been<br />

reported.<br />

Useful For: Evaluating patients' response to cancer therapy, especially for ovarian carcinoma<br />

Predicting recurrent ovarian cancer or intraperitoneal tumor<br />

Interpretation: In monitoring studies, elevated levels of cancer antigen 125 (CA 125) (>35 U/mL)<br />

are a predictor of the presence of intraperitoneal tumor or recurrence. Elevated concentrations have been<br />

found in about 72% of patients with surgically proven recurrent ovarian carcinoma. However, normal<br />

levels do not rule out recurrence. A persistently rising CA 125 value suggests progressive malignant<br />

disease and poor therapeutic response. Physiologic half-life of CA 125 is approximately 5 days. In<br />

patients with advanced disease who have undergone cytoreductive surgery and are on chemotherapy, a<br />

prolonged half-life (>20 days) may be associated with a shortened disease-free survival.<br />

Reference Values:<br />

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!